ArticleHaematologica2016

Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia.

Martin F M de Rooij et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.